ENSAT Stage III Adrenal Cortex Carcinoma
1 clinical trials · Condition
◉ Watch ENSAT Stage III Adrenal Cortex Carcinoma
| Record | Firm | Date |
|---|---|---|
| Mitotane With or Without Cisplatin and Etoposide After Surgery in Treating Patients With Stage I-III Adrenocortical Cancer With High Risk of Recurrence (NCT03583710) | M.D. Anderson Cancer Center | 2018-08-20 |
Track ENSAT Stage III Adrenal Cortex Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.